S. Naucke

2.5k total citations
10 papers, 1.5k citations indexed

About

S. Naucke is a scholar working on Molecular Biology, Hematology and Oncology. According to data from OpenAlex, S. Naucke has authored 10 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 8 papers in Hematology and 5 papers in Oncology. Recurrent topics in S. Naucke's work include Multiple Myeloma Research and Treatments (8 papers), Cancer therapeutics and mechanisms (3 papers) and Protein Degradation and Inhibitors (3 papers). S. Naucke is often cited by papers focused on Multiple Myeloma Research and Treatments (8 papers), Cancer therapeutics and mechanisms (3 papers) and Protein Degradation and Inhibitors (3 papers). S. Naucke collaborates with scholars based in United States. S. Naucke's co-authors include Bart Barlogie, Guido Tricot, Sundar Jagannath, D Bracy, David H. Vesole, S. Mattox, Bruce D. Cheson, Nikhil C. Munshi, K.R. Desikan and David S. Siegel and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Bone.

In The Last Decade

S. Naucke

10 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
S. Naucke United States 8 1.4k 931 674 198 94 10 1.5k
Dan Spoon United States 9 1.3k 1.0× 854 0.9× 671 1.0× 171 0.9× 76 0.8× 11 1.4k
C López-Berges Spain 13 1.3k 0.9× 619 0.7× 344 0.5× 399 2.0× 143 1.5× 20 1.4k
Anne‐Marie Stoppa France 19 1.2k 0.9× 756 0.8× 592 0.9× 141 0.7× 216 2.3× 54 1.4k
DH Vesole United States 11 1.2k 0.9× 557 0.6× 481 0.7× 103 0.5× 299 3.2× 12 1.3k
Bijay Nair United States 16 1.2k 0.9× 1.0k 1.1× 651 1.0× 206 1.0× 111 1.2× 40 1.5k
Cyrille Hulin France 21 2.1k 1.5× 1.5k 1.6× 1.2k 1.8× 197 1.0× 143 1.5× 106 2.3k
M Tribalto Italy 18 1.0k 0.8× 629 0.7× 515 0.8× 237 1.2× 141 1.5× 47 1.3k
Víctor H. Jiménez‐Zepeda Canada 20 728 0.5× 914 1.0× 588 0.9× 272 1.4× 104 1.1× 102 1.3k
RA Kyle United States 12 540 0.4× 542 0.6× 297 0.4× 163 0.8× 50 0.5× 17 826
Jeff Haessler United States 11 861 0.6× 666 0.7× 521 0.8× 98 0.5× 25 0.3× 16 1.0k

Countries citing papers authored by S. Naucke

Since Specialization
Citations

This map shows the geographic impact of S. Naucke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Naucke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Naucke more than expected).

Fields of papers citing papers by S. Naucke

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S. Naucke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Naucke. The network helps show where S. Naucke may publish in the future.

Co-authorship network of co-authors of S. Naucke

This figure shows the co-authorship network connecting the top 25 collaborators of S. Naucke. A scholar is included among the top collaborators of S. Naucke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S. Naucke. S. Naucke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Siegel, David S., K.R. Desikan, Jayesh Mehta, et al.. (1999). Age Is Not a Prognostic Variable With Autotransplants for Multiple Myeloma. Blood. 93(1). 51–54. 5 indexed citations
2.
Barlogie, Bart, Sundar Jagannath, K.R. Desikan, et al.. (1999). Total Therapy With Tandem Transplants for Newly Diagnosed Multiple Myeloma. Blood. 93(1). 55–65. 368 indexed citations
3.
Siegel, David S., K.R. Desikan, Jayesh Mehta, et al.. (1999). Age Is Not a Prognostic Variable With Autotransplants for Multiple Myeloma. Blood. 93(1). 51–54. 173 indexed citations
4.
Barlogie, Bart, Sundar Jagannath, S. Naucke, et al.. (1998). Long-term follow-up after high-dose therapy for high-risk multiple myeloma. Bone. 1101–11071. 1 indexed citations
5.
Barlogie, Bart, Sundar Jagannath, S. Naucke, et al.. (1998). Long-term follow-up after high-dose therapy for high-risk multiple myeloma. Bone Marrow Transplantation. 21(11). 1101–1107. 39 indexed citations
6.
Tricot, Guido, Jeffrey R. Sawyer, Sundar Jagannath, et al.. (1997). Unique role of cytogenetics in the prognosis of patients with myeloma receiving high-dose therapy and autotransplants.. Journal of Clinical Oncology. 15(7). 2659–2666. 138 indexed citations
7.
Dhodapkar, Madhav V., Sundar Jagannath, David H. Vesole, et al.. (1997). Treatment of AL-Amyloidosis with Dexamethasone Plus Alpha Interferon. Leukemia & lymphoma. 27(3-4). 351–356. 46 indexed citations
8.
Barlogie, Bart, Sundar Jagannath, David H. Vesole, et al.. (1997). Superiority of Tandem Autologous Transplantation Over Standard Therapy for Previously Untreated Multiple Myeloma. Blood. 89(3). 789–793. 415 indexed citations
9.
Tricot, Guido, et al.. (1996). Is the Risk of Multiple Myeloma Increased in Patients with Silicone Implants?. Current topics in microbiology and immunology. 210. 357–359. 10 indexed citations
10.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026